5-Aminosalicylic Acid Modulates the Immune Response in Chronic Beryllium Disease Subjects.

about

5-Aminosalicylic Acid Modulates the Immune Response in Chronic Beryllium Disease Subjects.

Item

http://www.wikidata.org/entity/Q48110321

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

5-Aminosalicylic Acid Modulate ...... ic Beryllium Disease Subjects.

@en

5-Aminosalicylic Acid Modulate ...... ic Beryllium Disease Subjects.

@nl

type

Item

label

5-Aminosalicylic Acid Modulate ...... ic Beryllium Disease Subjects.

@en

5-Aminosalicylic Acid Modulate ...... ic Beryllium Disease Subjects.

@nl

prefLabel

5-Aminosalicylic Acid Modulate ...... ic Beryllium Disease Subjects.

@en

5-Aminosalicylic Acid Modulate ...... ic Beryllium Disease Subjects.

@nl

P1476

5-Aminosalicylic Acid Modulate ...... ic Beryllium Disease Subjects.

@en

P2093

Brian J Day

http://www.w3.org/2001/XMLSchema#string

Briana Q Barkes

http://www.w3.org/2001/XMLSchema#string

Jie Huang

http://www.w3.org/2001/XMLSchema#string

Li Li

http://www.w3.org/2001/XMLSchema#string

May Gillespie

http://www.w3.org/2001/XMLSchema#string

P2860

Beryllium sensitization progresses to chronic beryllium disease: a longitudinal study of disease risk

Beryllium sensitization and disease among long-term and short-term workers in a beryllium ceramics plant

Beryllium-stimulated release of tumor necrosis factor-alpha, interleukin-6, and their soluble receptors in chronic beryllium disease

The nuclear protein HMGB1 is secreted by monocytes via a non-classical, vesicle-mediated secretory pathway

The MOS 36-ltem Short-Form Health Survey (SF-36)

Release of chromatin protein HMGB1 by necrotic cells triggers inflammation

Glutathione transport is a unique function of the ATP-binding cassette protein ABCG2.

Programmed necrosis induced by asbestos in human mesothelial cells causes high-mobility group box 1 protein release and resultant inflammation.

Reexamination of the blood lymphocyte transformation test in the diagnosis of chronic beryllium disease.

P2888

s00408-017-0062-x

P304

103-114

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00408-017-0062-X

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

196

http://www.w3.org/2001/XMLSchema#string

P50

Lisa A Maier

P577

2017-10-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29080069

http://www.w3.org/2001/XMLSchema#string